Caroline Dalgliesh
Saad Aldalaqan
Christian Atallah
Dr Andrew Best
Dr Emma Scott
et al. | An ultra-conserved poison exon in the Tra2b gene encoding a splicing activator is essential for male fertility and meiotic cell division | 2025 |
|
Dr Emma Scott
Professor Craig Robson
| A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid ‘xenoautoantigen’ Neu5Gc in humans and the need for a standardised approach to quantification | 2024 |
|
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2024 |
|
Zainab Alebady
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Emma Lishman-Walker
Jesslyn Choo
et al. | CDC20 is regulated by the histone methyltransferase, KMT5A, in castration resistant prostate cancer | 2023 |
|
Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al. | Engineering prostate cancer in vitro: what does it take? | 2023 |
|
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al. | Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer | 2023 |
|
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al. | ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer | 2023 |
|
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al. | ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression | 2023 |
|
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al. | The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer | 2023 |
|
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al. | Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth | 2023 |
|
Dr Emma Scott
Rebecca Garnham
Adam Duxfield
Professor David Elliott
Dr Jennifer Munkley
et al. | Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer | 2022 |
|
Kayla Bastian
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
| Fut8 alpha-(1,6)-fucosyltransferase in cancer | 2021 |
|
Dr Jack Leslie
Dr Emma Scott
Professor Quentin Anstee
Professor Fiona Oakley
| Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma | 2021 |
|
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
| Tumour associated glycans: A route to boost immunotherapy? | 2020 |
|
Dr Jennifer Munkley
SR Gokul Krishnan
Gerald Hysenaj
Dr Emma Scott
Caroline Dalgliesh
et al. | Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer | 2019 |
|
Rebecca Garnham
Dr Emma Scott
Karen Livermore
Dr Jennifer Munkley
| ST6GAL1: A key player in cancer (Review) | 2019 |
|
Dr Jennifer Munkley
Dr Emma Scott
| Targeting Aberrant Sialylation to Treat Cancer | 2019 |
|
Dr Emma Scott
Professor Quentin Anstee
| The genetics of alcoholic liver disease and non-alcoholic steatohepatitis | 2018 |
|
Dr Emma Scott
Dr Jeremy Palmer
Professor Quentin Anstee
| Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD | 2017 |
|
